The Fight for CRISPR Patents

For over a decade, there has been a battle for the coveted patents relating to the CRISPR/Cas9 gene editing technique. Two main groups, the University of California and the Broad Institute, are litigating the rights to the patents specifically covering the editing of eukaryotic cells